|
|
|
|||||||||||||||
|
AwardsSummary of ASBMR Awards ProgramASBMR Esteemed Awards
Abstract-Based Awards
ASBMR Funding Programs Publications Award Young Investigator Awards The mission of the American Society for Bone and Mineral Research (ASBMR) is to be the premier society in the field of bone and mineral metabolism through promoting excellence in bone and mineral research, fostering integration of clinical and basic science, and facilitating the translation of that science to health care and clinical practice. One way in which ASBMR supports its mission and promotes excellence is by recognition of outstanding members by prestigious awards given annually. All ASBMR members are eligible for the awards below, except as restricted by specific award criteria.
William F. Neuman, Ph.D., was a world-renowned scientist in the field of mineral metabolism. His seminal work on bone-seeking isotopes as part of the Manhattan Project was followed by major works in the chemistry of mineral and matrix, the function of bone cells, the metabolism of parathyroid hormone, and the concept of bone membrane. Dr. Neuman, along with his wife Margaret, authored the seminal monograph "The Chemical Dynamics of Bone Mineral" in 1958. He and his associates formed the Department of Radiation Biology and Biophysics at Rochester, where he served as co-chair and then chairman. Click Here to View Past-Awardees
Fuller Albright, M.D., was a much beloved investigator and teacher whose unparalleled achievements include significant contributions to the study of the renal effects of parathyroid hormone, estrogen use in osteoporosis, Vitamin D resistant rickets, and establishment of the Endocrine Unit of the Massachusetts General Hospital. Click Here to View Past-Awardees
Frederic C. Bartter, M.D., was one of the finest scientists and clinical investigators in academic medicine. In conjunction with Dr. Fuller Albright he developed cortisone treatment for congenital adrenal hyperplasia, and with Dr. William Schwartz described the syndrome of inappropriate ADII secretion. In addition, Dr. Bartter elucidated the role of aldosterone and contributed significantly to the study of hyperparathyroidism. From 1951 to 1978 he served as Chief of the NIH Endocrine-Hypertension Branch, and then became Associate Chief of Staff for Research at the Veterans Administration Medical Center and Professor at the University of Texas. Click Here to View Past-Awardees
Louis V. Avioli, M.D., ASBMR's first President, was one of the world's leading medical authorities on osteoporosis and calcium metabolism. He pioneered research into the skeleton and methods for detecting vitamin D in the blood, and identified bone loss as a potentially curable condition. Louis Avioli was a founding member of ASBMR. His research, like his commitment to the ASBMR, mentorship and friendship, has had a profound impact on the field. There is also a memorial lecture named in Louis Avioli's honor at the ASBMR Annual Meeting. Click Here to View Past-Awardees
Shirley Hohl worked with the ASBMR from its inception, serving first as Executive Secretary, then as Consultant. She maintained the latter position until her death in 1996. Her presence markedly influenced the development of the Society and her contributions were fundamental to establishing the infrastructure of the Society and its success. Click Here to View Past-Awardees Throughout his career, Gideon A. Rodan, M.D. — the 9th ASBMR President and the first recipient of the ASBMR Excellence in Mentorship Award (now named the Gideon A. Rodan Excellence in Mentorship Award) — was a major contributor to the field of bone cell biology. As a pioneer in this field, Dr. Rodan carried out early, seminal studies in bone cell characterization, signal transduction and cellular and molecular biology. His outstanding scientific contributions include: isolation and characterization of the first transformed osteoblastic cell line (ROS 17), the dissection of the PTH signal transduction mechanisms, the concept of osteoblast-osteoclast interactions, the cloning of alkaline phosphatase, and the roles of steroids and prostaglandins in bone metabolism. As Director of the Department of Bone Biology and Osteoporosis Research at Merck, he fostered the development of the first bisphosphonate approved for treatment of osteoporosis and provided detailed studies of the mechanisms of action of the bisphosphonates. Besides his distinguished scientific accomplishments, Dr. Rodan was a leader
in service to the field, to the ASBMR, and to the education and training of
young investigators. The ASBMR Award for Outstanding Research in the Pathophysiology of Osteoporosis is given in recognition of the highest ranking abstract submitted to the Osteoporosis-Pathophysiology abstract category. The award includes a $1,500 honorarium and a plaque which is presented at the ASBMR Awards Reception held during the Annual Meeting. Nominations are not accepted. The members of the Program Committee select the award winner based only on the scientific merit of the abstract. This award is not limited to young investigators. All abstracts are scored using a "blind-review system" as described in detail in the Abstracts book. (One award is given per year.) The ASBMR Most Outstanding Abstract Award is given to the lead investigator of the highest scored abstract submitted for presentation at the ASBMR Annual Meeting. The award includes a $1,500 honorarium and a plaque which is presented at the ASBMR Awards Reception held during the Annual Meeting. Nominations are not accepted. The members of the Program Committee select the award winner based only on the scientific merit of the abstract. All abstracts are scored using a "blind-review system" as described in detail in the Abstracts book. (One award is given per year.) The ASBMR President's Award is given to the highest ranking abstract submitted by a student. The award includes a $1,500 honorarium and a plaque which is presented at the ASBMR Awards Reception held during the Annual Meeting. Nominations are not accepted. The members of the Program Committee select the award winner based only on the scientific merit of the abstract. All abstracts are scored using a "blind-review system" as described in detail in the Abstracts book. (One award is given per year.) The ASBMR Young Investigator Award recognizes young investigators for their excellence in bone and mineral research. Nominations are not accepted. To select the award winners, ASBMR identifies the eligible investigators whose abstracts attained the highest ranked positions within their respective categories, using the abstract reviewers' "blind-review system" of scoring abstracts as described in the Abstracts book. Initial award designations are preliminary, and are finalized contingent upon validation of eligibility criteria and presentation of the abstract by the young investigator at the annual meeting. Award Recipients must: 1) be the first AND presenting author of the abstract The five years of eligibility are defined to extend from the end of the calendar year of the date of graduation or, if applicable, of completion of residency training or clinical subspecialty fellowship training, to the submission deadline date. Clinical subspecialty fellowship training is considered to end no later than the point at which the individual becomes board eligible. The above eligibility criteria include students or trainees who have not yet obtained their doctoral degree. Individuals with special circumstances, e.g., for whom postdoctoral research did not commence within one year of graduation or, if applicable, of completion of clinical training, may petition the ASBMR to consider an extension of the term of eligibility defined above. However, petitions to the ASBMR regarding award eligibility must occur prior to the submission of the abstract (prior to April 16, 2008). The award includes a $1,000 honorarium and a plaque. The ASBMR expects that $500 of the honorarium will be used to help offset travel expenses to the Annual Meeting. The other $500 may be used by the recipient at his/her discretion. If an individual selected to receive a Young Investigator Award does not present his or her abstract at the meeting, or is found to have not fulfilled eligibility criteria, the award will be cancelled and/or forfeited.
|
| Home | Search | Site Map | Disclaimer | Contact Us |
Privacy Policy Refund/Return Policy Linking Policy